Apaluside 60mg Tablet
Prescription Required
Marketed By
Lucien Life Science
Pack of
120 tablet(s) in a bottle
Salt Composition
Apalutamide
Storage
Keep in cold place
₹29850₹37500
20.40% Off
Inclusive of all taxes
1
Apaluside 60mg Tablet
Delivering To: —
Description
Apaluside 60mg tablet is a prescription based medication which is highly used medication in advanced prostate cancer in adult men. The medication is a selective androgen receptor (AR) inhibitor, that binds directly to the androgen (testosterone). It inhibits the formation of protein which is responsible for the production of cancer cells and reduces cancer cell growth or increases cell death. Apalutamide is an active ingredient of Apaluside responsible for these anti-cancer effects. Doctor supervision is needed in the treatment to ensure correct dosage and monitor for side effects.
Indication
Treat advanced prostate cancer in adult men.
Common Side Effects
● Brain tumor
● Diabetes
● Head injury
● Heart disease
● High blood pressure
● High cholesterol
● Osteoporosis, weak bones
● Seizures
● Stroke
Dosage And Duration
Apaluside tablet should be taken orally in 60mg concentration. Take the medicine with or without food at the same time everyday. Dose adjustment may be required in patients with severe liver impairment or those experiencing significant adverse effects. Patient should be monitored for signs of prostate cancer progression, liver function and overall health status.
Mechanism Of Action
Apalutamide works by binding to the androgen receptor in prostate cancer cells and blocking the production of testosterone which is responsible for growing cancer cells in the body. This action inhibits the signaling pathways that drives the growth and proliferation of prostate cancer cells. This helps slow the progression of the disease, induces apoptosis of malignant cells, thereby contributing to improved clinical outcomes in patients with advanced prostate cancer.
Safety Advice
Alcohol
unsafe
Alcohol is not good for health, taking it while using Apaluside 60mg tablet may reduce the effectiveness of the treatment. Avoid using it as it can interfere with therapy.
Driving
danger
Apaluside 60mg tablet does not affect the ability of driving, still if the patient feel dizziness during the treatment, avoid driving or operating heavy machinery.
Pregnancy
unsafe
Pregnant women should avoid Apaluside 60mg tablet as it harm the fetus.
Breast Feeding
consult your doctor
Apaluside 60mg tablet is not prescribed by healthcare professional without proper medical evaluation.
Kidney
caution
Doctors are not prescribed Apaluside 60mg tablet to kidney patients as it may worsen kidney function and cause harmful side effects.
Liver
unsafe
Apaluside 60mg tablet is not recommended for liver patients as it may increase the risk of liver damage.
Faqs
Apaluside 60mg treats advanced prostate cancer in adult men by blocking the progression of androgen hormones which is responsible for the production of cancer cells in the body.
Apaluside 60mg tablet is targeted therapy which specifically targets the tumor cells without damaging the healthy cells and protect the body from other disease which can reduce side effects compared to traditional chemotherapy.
Apaluside tablet may cause infertility in certain males. Take a prescription from the healthcare provider if you are planning for the baby.
Apaluside can be taken with other medication but only under doctor prescription to ensure safety and effectiveness of the treatment.
Apaluside should be taken with or without food at the same time everyday to enhance the effectiveness of the medication. It is a highly prescribed medication in prostate cancer, consult the doctor before taking the medication.
References
• Chi, K. N., Agarwal, N., Bjartell, A., Chung, B. H., Pereira de Santana Gomes, A. J., Given, R., ... & Chowdhury, S. (2019). Apalutamide for metastatic, castration-sensitive prostate cancer. New England Journal of Medicine, 381(1), 13-24.
• Smith, M. R., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B. A., Graff, J. N., ... & Small, E. J. (2021). Apalutamide and overall survival in prostate cancer. European urology, 79(1), 150-158.
• Smith, M. R., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B. A., Graff, J. N., ... & Small, E. J. (2018). Apalutamide treatment and metastasis-free survival in prostate cancer. New England Journal of Medicine, 378(15), 1408-1418.
• Rathkopf, D. E., & Scher, H. I. (2018). Apalutamide for the treatment of prostate cancer. Expert review of anticancer therapy, 18(9), 823-836.
• Al-Salama, Z. T. (2018). Apalutamide: first global approval. Drugs, 78(6), 699-705.
Related Products
MARKETER DETAILS
Lucien Life Science
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.